In 2020, more than 2.7 million people were diagnosed with cancer in the European Union (EU), whereas 1.3 million people died from cancer. By 2035, the number of cancer cases is expected to increase by 24%, making cancer the leading cause of death in the EU. Currently, the leading specific molecular imaging technique for cancer diagnosis is based on positron emission tomography (PET), which is available in less than 0.5% of medical centers worldwide, mainly due to the high cost of PET scanners.
In the European Innovation Council project PetVision, coordinated by Assoc. Prof. Dr. Rok Pestotnik from Jozef Stefan Institute, we are developing a new generation of devices that will enable completely modular, affordable, and adaptable PET scanners by means of precise time measurement.
In this lecture (in Slovene language), Rok Pestotnik presents the ๐ญ๐ฐ๐ฏ๐จ-๐ต๐ฆ๐ณ๐ฎ ๐ท๐ช๐ด๐ช๐ฐ๐ฏ, ๐ฑ๐ณ๐ฐ๐ซ๐ฆ๐ค๐ต ๐จ๐ฐ๐ข๐ญ๐ด ๐ข๐ฏ๐ฅ ๐ฃ๐ณ๐ฆ๐ข๐ฌ๐ต๐ฉ๐ณ๐ฐ๐ถ๐จ๐ฉ๐ด ๐ช๐ฏ ๐ต๐ฉ๐ฆ ๐ฅ๐ฆ๐ด๐ช๐จ๐ฏ ๐ฐ๐ง ๐ต๐ฉ๐ฆ ๐ฅ๐ฆ๐ต๐ฆ๐ค๐ต๐ฐ๐ณ, ๐ฑ๐ฉ๐ฐ๐ต๐ฐ๐ด๐ฆ๐ฏ๐ด๐ฐ๐ณ ๐ข๐ฏ๐ฅ ๐ฅ๐ข๐ต๐ข ๐ข๐ค๐ฒ๐ถ๐ช๐ด๐ช๐ต๐ช๐ฐ๐ฏ ๐ฆ๐ญ๐ฆ๐ค๐ต๐ณ๐ฐ๐ฏ๐ช๐ค๐ด.
